Back

Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort

30 August 2026 (14:30 - 14:42)
Organised by: Logo
Congress Presentation Part of: Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Jaiveer Singh

(United States of America)

4 More presentations in this session

Presentation thumbnail
Artificial intelligence–enabled electrocardiography as a pre-treatment predictor of chemotherapy-related cardiac dysfunction
Doctor M. Lee (Bucheon, KR)
Abstract
Presentation thumbnail
GLP-1 receptor agonists for anthracycline-associated cardiac outcomes: first meta-analytic evaluation in propensity-matched cohorts
Mr A. Chauhan (IN)
Abstract
Presentation thumbnail
Healthcare utilization and costs in cancer therapy-related heart failure: a national inpatient sample analysis
Doctor L. Cruz (Santiago de los Caballeros, DO)
Abstract
Presentation thumbnail
Stratification of cancer-therapy related cardiac dysfunction: a validated prediction tool to identify low risk patients.
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract

Access the full session

Session thumbnail
Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection

The Event

Event poster

ESC Congress 2026

30 August 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Clonal hematopoiesis of indeterminate potential and clinical characteristics in hypertrophic cardiomyopathy
11 December 2024
thumbnail
Congress Presentation
Diastolic dysfunction is associated with development of heart failure in patients with breast cancer under chemotherapy
22 May 2023
thumbnail
Congress Presentation
Cardiovascular complications of chimeric antigen receptor (CAR)-t cell therapy: insights from a regional cardio-oncology program
21 June 2025
thumbnail
Congress Presentation
Latest developments in clonal hematopoiesis and implications for cardiovascular diseases
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources